Medical Assistance in Dying, widely known by the acronym MAiD, is the practice of a physician or nurse practitioner helping a patient end their life, either by directly administering lethal medication (euthanasia) or by prescribing medication the patient takes themselves (assisted suicide). Canada’s framework, which uses the term MAiD specifically, has become one of the most closely watched in the world because it has expanded rapidly since legalization in 2016, moving from access limited to people near the end of life to a broader system that now includes individuals whose death is not imminent. The details of who qualifies, how the process unfolds, and where the boundaries should be drawn remain subjects of intense debate among clinicians, ethicists, disability advocates, and the public.
Where MAiD and Assisted Dying Are Legal
The legal landscape varies widely by country and, in some cases, by region within a country. In Europe, Spain, Portugal, Luxembourg, and the Netherlands permit both euthanasia and physician-assisted suicide, while Belgium limits access to euthanasia alone, and Austria, Germany, and Switzerland regulate only assisted suicide.1PubMed Central. Comparative legal and bioethical perspectives on euthanasia and assisted suicide: a systematic review of european frameworks In North America, Canada’s MAiD regime covers both forms. Several U.S. states permit physician-assisted suicide under their own “Death with Dignity” or “medical aid in dying” statutes, though none allows euthanasia. Australia and New Zealand have enacted their own assisted dying laws in recent years.
Even among countries that permit some form of assisted death, the rate of use differs substantially. A population-level comparison of Belgium, the Netherlands, and Switzerland found that assisted deaths accounted for roughly 4.6 percent of all deaths in both Belgium and the Netherlands, compared with about 1.4 percent in Switzerland. The people who died this way were mostly aged 65 or older, and cancer was the most common diagnosis in Belgium and the Netherlands.2PubMed. Commonalities and differences in legal euthanasia and physician-assisted suicide in three countries: a population-level comparison In the U.S. states of Oregon and Washington, numbers have risen over time but remain a much smaller share of total deaths.3JAMA Network Open. Trends in Medical Aid in Dying in Oregon and Washington
How Canada’s MAiD Framework Evolved
Canada legalized MAiD in 2016 with Bill C-14, which required that a person’s natural death be “reasonably foreseeable.” In practice, this limited the procedure largely to people with terminal conditions. Before clinicians and health systems had even fully settled into that framework, new legislation arrived. Bill C-7, which took effect in March 2021, extended eligibility to people whose natural death is not reasonably foreseeable, creating what practitioners call “Track 2.”4PubMed Central. Navigating medical assistance in dying from Bill C-14 to Bill C-7: a qualitative study The country’s framework had effectively shifted from a complete prohibition to a regulatory scheme that permits access even when conditions are not imminently life-ending.5Medicina e Morale. Assisted dying for non-terminal suffering: a legal analysis of existential distress as a threshold condition in Canada
This evolution has been among the fastest of any jurisdiction. Most European countries that legalized assisted dying did so incrementally over decades, often through multiple rounds of parliamentary debate. Canada compressed a great deal of change into a few years, and further expansions remain under active consideration.
Who Qualifies and How Eligibility Is Assessed
Under Canada’s current law, anyone requesting MAiD must be a Canadian citizen or permanent resident, at least 18 years old, capable of making health decisions, and experiencing intolerable physical or psychological suffering from a grievous and irremediable medical condition. Two independent clinicians or nurse practitioners must assess the person and confirm that all criteria are met. If the person’s natural death is reasonably foreseeable (Track 1), there is a 10-day reflection period. If it is not (Track 2), the reflection period extends to 90 days and the person must be assessed by a practitioner with expertise in the condition causing their suffering.
Track 2 requests are more complex in practice. A survey of providers who handled early Track 2 cases found that chronic pain syndromes were the most common diagnosis, affecting about half of the patients. Around 15 percent had conditions like myalgic encephalomyelitis or chronic fatigue syndrome. Roughly two-thirds of assessments involved the challenge of a patient having a concurrent mental illness, and in about a third of cases, providers felt the patient had not yet been offered all appropriate treatments.6PubMed Central. Medical assistance in dying when natural death is not reasonably foreseeable: Survey of providers’ experiences with patients making track 2 requests These cases require substantial coordination. Clinicians who handle them describe the work as emotionally demanding and sometimes poorly compensated. Team-based MAiD coordination centres that provide structured intake, education, and interdisciplinary case consultation have proven helpful, especially when the person requesting MAiD has no regular primary care provider.7PubMed Central. Developing robust systems for Track 2 MAID in Canada: A qualitative study
Telemedicine has also played a growing role. A mixed-methods study found that virtual eligibility assessments were highly acceptable to patients, their support persons, and most assessors. Assessors noted challenges with reading nonverbal cues and maintaining eye contact through a screen, but overall, telemedicine improved access and equity for patients who would otherwise face geographic barriers.8PubMed Central. Quality of care with telemedicine for medical assistance in dying eligibility assessments: a mixed-methods study
Who Requests MAiD and Why
The typical MAiD recipient tends to be older, though not as old as people sometimes assume. At one Canadian tertiary hospital, the median age of patients who received MAiD was 74, and cancer was the primary diagnosis for about four in five cases. The most commonly cited reason, reported by nearly two-thirds of patients, was functional decline or the inability to participate in meaningful activities, rather than uncontrolled pain.9PubMed. Medical Assistance in Dying (MAiD): A Descriptive Study From a Canadian Tertiary Care Hospital Loss of autonomy, loss of dignity, and the inability to enjoy life consistently rank among the top motivations in multiple jurisdictions, often outranking pain itself.
A closer look at older adults tells a more detailed story. Among patients assessed for MAiD in one Canadian study, about 38 percent were over 80. Those in this oldest group were more likely to be female, to live alone, and to be widowed, though they did not describe themselves as socially isolated. They were also more likely to have chronic or subacute conditions rather than straightforward terminal diagnoses like cancer.10PubMed Central. Characteristics of Older Adults Accessing Medical Assistance in Dying (MAiD): a Descriptive Study This pattern highlights a tension that runs through the broader debate: when the primary driver is accumulated decline rather than a single disease, the line between medical suffering and the hardships of aging can feel blurry.
What Happens During the Procedure
MAiD can take two forms: self-administered (the person drinks or otherwise ingests the lethal medication) or clinician-administered (a clinician delivers the drugs intravenously). In Canada, the vast majority of cases are clinician-administered. In U.S. states where only assisted suicide is legal, the patient must take the medication themselves.
The drugs used vary by jurisdiction and by method. For self-administered assisted death, high doses of barbiturates, usually pentobarbital or secobarbital, have long been the standard and are recommended in both the Dutch euthanasia guidelines and Canadian clinical protocols. In some U.S. states, multi-drug combinations have been used instead, pairing agents like diazepam, digoxin, morphine, and either amitriptyline or propranolol. For clinician-administered euthanasia, the typical approach involves first giving a general anesthetic, often a barbiturate or propofol, to induce unconsciousness, followed by a neuromuscular blocking agent that stops breathing.11PubMed Central. Efficacy and safety of drugs used for ‘assisted dying’ The intention is for the person to fall unconscious within seconds and die within minutes, painlessly and without awareness.
Complications are uncommon but not unheard of. The oral route carries more variability because absorption depends on the individual’s physiology. Nausea, vomiting, or a prolonged time to death have been reported in a small number of self-administered cases. The intravenous route is faster and more predictable, which is one reason clinician-administered euthanasia predominates in countries where both options are available.
The Frontier Issues: Mental Illness, Dementia, and Minors
Canada originally planned to extend MAiD eligibility to people whose sole underlying condition is a mental illness, but that expansion has been repeatedly delayed and, as of mid-2025, remains paused. The prospect has generated some of the fiercest debate in the MAiD landscape. A qualitative study that included both people with mental illness and their family members found a range of views: some saw MAiD for mental illness as an individual’s right to end intolerable suffering, while others described it as fundamentally indistinguishable from suicide, even if the process is more controlled. Many participants held both views simultaneously, acknowledging that MAiD could be a humane alternative to violent self-harm while also recognizing the overlap with suicidality.12PubMed Central. Medical Assistance in Dying for Mental Illness as a Sole Underlying Medical Condition and Its Relationship to Suicide: A Qualitative Lived Experience-Engaged Study
Dementia raises different challenges. Currently, a person must have decision-making capacity at the time the MAiD procedure is performed, which means someone with advancing dementia cannot receive MAiD once they lose the ability to consent. This has fueled growing interest in advance requests, where a person sets out their wishes in an advance directive while still capable. A survey of dementia care specialists found that about two-thirds agreed MAiD should be available through advance directives, with most saying the directive should be created during the mild stage and enacted during the moderate or severe stage. Yet the same clinicians flagged serious concerns about safety, and about two-thirds said enacting such a directive once capacity is lost would be difficult.13PubMed Central. Advance Requests for Medical Assistance in Dying in Dementia: a Survey Study of Dementia Care Specialists Advocates for advance requests argue that barring them forces people with early dementia into an impossible position: they can request MAiD only while still well enough to have capacity, which may be earlier than they would otherwise want to die.14Canadian Journal of Bioethics. Why Not Advance Directives for MAID in Those with Dementia?
Access for minors, sometimes called “mature minors,” is another unresolved question. The Netherlands and Belgium already allow young people under 18 to access assisted dying under specific conditions, with their frameworks emphasizing unbearable suffering and the minor’s capacity to understand the decision. Canada has not extended MAiD to minors, and the question of whether adolescents can possess sufficient decision-making capacity for such a choice remains unsettled in the Canadian legal context.15PubMed. Exploring assisted dying policies for mature minors: A cross jurisdiction comparison of the Netherlands, Belgium & Canada
The Social Determinants Concern
One of the sharpest criticisms of MAiD expansion comes from disability rights advocates and public health scholars who point to the role of social determinants of health. The argument is straightforward: if a person’s suffering stems not from their medical condition alone but from poverty, inadequate housing, social isolation, or inaccessible health care, then offering assisted death without first addressing those failures is a troubling shortcut. Research supports the concern that both disability and mental illness can erode a person’s social circumstances in ways that compound over time, including reduced income, loss of social connections, and restricted access to timely health care.16PubMed Central. Social determinants of health and slippery slopes in assisted dying debates: lessons from Canada
This criticism carries real weight in the Track 2 context. Recall that in the early Track 2 survey, about a third of providers felt their patients had not been offered all appropriate treatments before requesting MAiD.17PubMed Central. Medical assistance in dying when natural death is not reasonably foreseeable: Survey of providers’ experiences with patients making track 2 requests When someone asks to die because they cannot access adequate pain management, housing, or mental health services, the question of whether MAiD is truly a free choice becomes hard to sidestep. Supporters of expanded access counter that withholding MAiD does not fix the underlying service gaps, and that competent adults should not be forced to wait for a social safety net that may never arrive. The tension is genuine and unresolved.
What Families Experience After a MAiD Death
Families and friends who lose someone to MAiD often describe a complicated emotional experience, but the research to date is broadly reassuring. A scoping review found that bereaved family and friends of people who died by euthanasia had fewer traumatic grief symptoms and fewer post-traumatic stress reactions compared with those who lost someone to cancer through a natural death.18PubMed Central. Grief and bereavement of family and friends around medical assistance in dying: scoping review An Oregon-based study found no differences in depression, prolonged grief, or mental health service use between families of people who requested aid in dying and those who did not. Family members of people who used a lethal prescription were more likely to feel their loved one’s choices had been honored and less likely to have regrets about how the death unfolded.19PubMed. Mental health outcomes of family members of Oregonians who request physician aid in dying
A mixed-methods comparison of grief after MAiD versus natural death with palliative care found no statistically significant differences in grief outcomes, and scores did not suggest grief complications in either group. That said, the qualitative portion of the study was more nuanced: some family members described positive imprints from the sense of control and dignity, while others carried difficult memories of the process itself. Both MAiD and natural deaths could interact with other risk factors to produce hard grief experiences for some individuals.20PubMed Central. To Lose a Loved One by Medical Assistance in Dying or by Natural Death with Palliative Care: A Mixed Methods Comparison of Grief Experiences The overall picture is that MAiD does not seem to add grief burden on average, and may ease certain aspects of bereavement, but individual experiences vary and no death is uncomplicated.
Conscientious Objection and Institutional Barriers
Not all clinicians are willing to participate in MAiD, and most jurisdictions protect their right to refuse. Conscientious objection policies typically require the objecting clinician to refer the patient to a willing provider or an information service, though the specifics vary. The ethical discussion around conscientious objection has moved beyond a simple yes-or-no framing. A relational ethics analysis of MAiD in Canada argued that policies should account for the moral distress clinicians experience when they feel unable to provide what they consider excellent care, whether that distress comes from being asked to participate in MAiD or from being prevented from helping a patient access it.21Journal of Medical Ethics. Conscientious objection and moral distress: a relational ethics case study of MAiD in Canada
At the institutional level, some organizations, particularly faith-based hospitals and care facilities, refuse to allow MAiD on their premises. A Canadian qualitative study found that such institutional objections have resulted in forced patient transfers and negative emotional and psychological impacts on patients, families, and health practitioners alike.22PubMed Central. A qualitative study of experiences of institutional objection to medical assistance in dying in Canada: ongoing challenges and catalysts for change For a dying person, being told they must leave the facility where they have been receiving care to access a legally available procedure can be deeply distressing. Several Canadian provinces have introduced or considered legislation requiring institutions that receive public funding to allow MAiD on-site, though this remains politically contentious.
Organ Donation After MAiD
An emerging and sometimes surprising intersection is organ donation following MAiD. Because MAiD is a planned death, it is possible to coordinate organ retrieval more effectively than in most end-of-life scenarios. Canada, Belgium, and the Netherlands have all seen cases of organ donation after assisted death, and the practice is growing. The ethical terrain, however, is delicate. Recommendations from the Ethics Committee of the Transplantation Society identified three core concerns: safeguarding the patient’s voluntary decision-making so that the possibility of donation does not influence the choice to die; maintaining ethical governance around how and when death is determined; and supporting the professionals involved, including protections for those who conscientiously object to participating.23PubMed Central. Ethical Implementation of Organ Donation Following Medical Assistance in Dying: Recommendations of the Ethics Committee of the Transplantation Society
Guidelines generally require that the MAiD request and assessment be entirely complete before any conversation about organ donation begins, preventing even the appearance of undue influence. For patients who do wish to donate, the controlled timing of death can mean their organs are in better condition than those recovered after a prolonged natural dying process, which has the potential to benefit recipients. How widely this practice will expand depends on both public acceptance and the development of clear protocols that keep the two decisions, to die and to donate, firmly separated.